Healthcare Venture Launched by Amazon, JPMorgan and Berkshire Hathaway Goes Bust
Haven—the healthcare company formed by Amazon, JPMorgan Chase and Berkshire Hathaway—is apparently no more. The healthcare company began telling employees [...]
Hospitals Lose Another Attempt to Stave Off Price Transparency
A federal appeals court ruled against hospitals' efforts to stop regulators from forcing them to reveal the secret negotiated prices [...]
How Does Cost-Sharing Impact Spending Growth and Cost-Effective Treatments?
The growth of health care spending has been a longstanding policy concern. Over the years, several innovations have been proposed [...]
Impact of the Pandemic on Medical and Scientific Affairs
In the latest episode of Impetus Digital's Fireside Chat, Dr. Shurjeel Choudhri, SVP and Head, Medical and Scientific Affairs, Bayer [...]
The Medical Science Liaison-DISC Personality Types Survey
The MSL role is constantly evolving and facing new challenges. MSLs are both scientific experts and relationship managers. As such, [...]
Trends That Matter for COVID Vaccine Distribution
As details continue to emerge about the availability of COVID-19 vaccines and how they will be administered, the role that [...]
Drug Wholesale Prices Impact Payer Spending, Out-of-pocket Costs
Increases in drug wholesale list prices have a trickle-down effect that negatively impacts patient financial responsibility, such as out-of-pocket costs, [...]
Use of Real-world Evidence in Economic Assessments of Pharmaceuticals in the US
In a recent study, investigators from the University of Washington School of Pharmacy reviewed cost-effectiveness and budget impact analyses in [...]
How Healthcare is Leveraging Real-World Data to Improve Outcomes
To improve outcomes during the COVID-19 pandemic and beyond, organizations are using real-world data for efficient and effective decision-making. At [...]
Scientist.com Reflects on the Resounding Successes of 2020
As 2020 comes to a close, we'd like to thank you for supporting our mission here at Scientist.com. Whether you [...]
Employee Health Data Analyses Must Include Race And Ethnicity
As the COVID-19 pandemic has highlighted, at the core of racial equity and social justice movements are health disparities along [...]
[On-demand Conference] Real World Evidence: Meet the Future with Confidence
COVID-19 is impacting all of us and challenging previous ways of working. This is a period of disruption. In this [...]
NICE Updates Methods for Health Technology Evaluations
On November 6, 2020, NICE published a summary of its proposed changes to health technology evaluation methods. NICE periodically assesses its methods [...]
eBook: The role of RWE in FDA approvals
As industry prepares for the FDA’s draft RWE guidance in 2021, Aetion conducted a systematic review of FDA approval documents [...]
ICER Publishes Final Evidence Report for Bladder Cancer Therapies
The Institute for Clinical and Economic Review (ICER) today released a Final Evidence Report and Report-at-a-Glance assessing the comparative clinical effectiveness and value of [...]
PRECISIONxtract Increasing Life Sciences Commercialization Capabilities
PRECISIONxtract, a Precision Value & Health team, announced the launch of two new and innovative product lines, EHR Connect™ and Access [...]
Addressing the Affordability Crisis of Cell & Gene Therapies
In a recent Reuters Events poll, 43% of pharma said that reimbursement policy and legislation (e.g Best Price) is the [...]
GoodRx Adds Telehealth and Mail-delivery
GoodRx, announced this morning that it was adding telehealth and mail-delivery to its subscription savings program, called GoodRx Gold, giving members [...]
RxAdvance’s Sculley: What the PBM of the Future Might Look Like
The traditional models for pharmacy benefit managers have been under particular scrutiny of late, with these companies seeing the revival and [...]
Identifying High-Risk COVID Patients Through Early Symptoms and Other Risk Factors
As cases of the coronavirus continue to rise in the US and globally, there is increasing need to find more [...]
Digital Health Outcomes partners with the Institute for Clinical and Economic Review (ICER)
We are celebrating the launch of the next generation interactive modelling platform! Many thanks to our clients and partners, especially [...]
Scientist.com to Acquire HealthEconomics.Com, the World’s Leading Connected Community for Health Economics and Outcomes Research
Scientist.com, the healthcare industry’s leading marketplace for outsourced R&D, announced today it will acquire HealthEconomics.Com, a private US-based company that [...]
[Podcast] The Conflict Between QALYs for Drug Value and Patient Advocacy Groups
In the latest episode of the Relentless Health Value podcast, Stacey Richter interviews Memorial Sloan Kettering’s Anna Kaltenboeck about how [...]
Trump’s Drug-card Plan Hits Another Roadblock
Trump’s plan, which blindsided health officials in September, came as the president sought to reverse declining poll numbers among “our [...]
Pandemic Tames Healthcare Cost Growth for Some Employers
Large U.S. employers saw their smallest health care cost increase in more than two decades due to COVID-19, and workers [...]